MBX Biosciences

About:

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Twitter/X: mbxbio

Top Investors: New Enterprise Associates, OrbiMed, RA Capital Management, Norwest Venture Partners, BioCrossroads

Description:

MBX Biosciences is a biotechnology company that develops therapies to treat rare endocrine diseases where there is inadequate treatment available. It focuses on the discovery, development, and commercialization of first-in-class endocrine therapeutics.

Total Funding Amount:

$238M

Headquarters Location:

Carmel, Indiana, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)mbxbio.com

Founders:

P. Kent Hawryluk, Tim Knickerbocker

Number of Employees:

11-50

Last Funding Date:

2024-08-05

IPO Status:

Public

Industries: